MammaPrint Test Addressed in ASCO Breast Cancer Guideline Update

July 11, 2017 – New recommendations on the use of the MammaPrint genomic test issued on July 10 will help guide decisions on adjuvant systemic therapy for women with early breast cancer. The recommendations update the ASCO 2016 clinical practice guideline on the use of biomarkers in these patients. The guideline update was … (leggi tutto)